Hearing Loss Trial, Recruiting NCT05668338 Sponsor: MED-EL Elektromedizinische Geräte GesmbH Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT05668338
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children or adults who have already received, or are planned to receive, a hearing implant in one or both ears from the company MED-EL (either at the same time or in separate procedures).
  • Children or adults who have already received, or are planned to receive, a non-surgically implanted hearing device in one or both ears from MED-EL.
  • Children or adults who are current users of a MED-EL hearing solution — this includes cochlear implants, electric-acoustic devices, bone-anchored hearing devices, middle ear implants, or other hearing devices from MED-EL, whether used in one ear, both ears, or in combination with another hearing aid.
  • People who have signed a written consent form agreeing to have their data collected for this registry.

Who may not be able to join:

  • People who do not meet all of the inclusion criteria listed above.
  • People for whom the trial investigator believes participation would put them at greater risk, or who may not be able to fully complete all of the registry procedures for any reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel Polterauer-Neuling, Dr., Klinikum der Universität München Campus Großhadern

Phone: +43 57 788 1694

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
MED-EL Elektromedizinische Geräte GesmbH
Registry
ClinicalTrials.gov
Start date
26 June 2017
Est. completion
1 December 2030

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Subject Demographics; Hearing Threshold level; Speech test; HISQUI (Hearing Implant Sound Quality Index); APHAB (Abbreviated Profile of Hearing Aid Benefit); ASC (Auditory Skills Checklist); APSQ (Audio Processor Satisfaction Questionnaire); LEAQ (LittlEars Auditory Questionnaire); HL-QOL

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov